<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">51739</article-id><article-id pub-id-type="doi">10.7554/eLife.51739</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>A phenotypic screening platform utilising human spermatozoa identifies compounds with contraceptive activity</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-160885"><name><surname>Gruber</surname><given-names>Franz S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-167834"><name><surname>johnston</surname><given-names>Zoe C</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-27310"><name><surname>Barratt</surname><given-names>Christopher LR</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0062-9979</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-160884"><name><surname>Andrews</surname><given-names>Paul D</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7699-5604</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">School of Life Sciences</institution>, <institution>University of Dundee</institution>, <addr-line><named-content content-type="city">Dundee</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Division of Systems Medicine</institution>, <institution>University of Dundee</institution>, <addr-line><named-content content-type="city">Dundee</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-5290"><name><surname>Lishko</surname><given-names>Polina V</given-names></name><role>Reviewing editor</role><aff><institution>University of California, Berkeley</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>c.barratt@dundee.ac.uk</email> (CB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>28</day><month>01</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e51739</elocation-id><history><date date-type="received"><day>09</day><month>09</month><year>2019</year></date><date date-type="accepted"><day>19</day><month>01</month><year>2020</year></date></history><permissions><copyright-statement>Â© 2020, Gruber et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Gruber et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-51739-v1.pdf"/><abstract><p>There is an urgent need to develop new methods for male contraception, however a major barrier to drug discovery has been the lack of validated targets and the absence of an effective high-throughput phenotypic screening system. To address this deficit, we developed a fully-automated robotic screening platform that provided quantitative evaluation of compound activity against two key attributes of human sperm function: motility and acrosome reaction. In order to accelerate contraceptive development, we screened the comprehensive collection of 12,000 molecules that make up the ReFRAME repurposing library, comprising nearly all the small molecules that have been approved or have undergone clinical development, or have significant preclinical profiling. We identified several compounds that potently inhibit motility representing either novel drug candidates or routes to target identification. This platform will now allow for major drug discovery programmes that address the critical gap in the contraceptive portfolio as well as uncover novel human sperm biology.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000865</institution-id><institution>Bill and Melinda Gates Foundation</institution></institution-wrap></funding-source><award-id>OPP1160989</award-id><principal-award-recipient><name><surname>johnston</surname><given-names>Zoe C</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000865</institution-id><institution>Bill and Melinda Gates Foundation</institution></institution-wrap></funding-source><award-id>OPP1203050</award-id><principal-award-recipient><name><surname>Gruber</surname><given-names>Franz S</given-names></name><name><surname>johnston</surname><given-names>Zoe C</given-names></name><name><surname>Barratt</surname><given-names>Christopher LR</given-names></name><name><surname>Andrews</surname><given-names>Paul D</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. The Funders did facilitate using  the REFRAME library</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Christopher LR Barratt, Editor for RBMO, has received lecturing fees from Merck, Pharmasure and Ferring and was on the Scientific Advisory Panel for Ohana BioSciences.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Written consent was obtained from each donor in accordance with the Human Fertilization and Embryology Authority (HFEA) Code of Practice (version 8) under local ethical approval (13/ES/0091) from the Tayside Committee of Medical Research Ethics B.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Full data is available. Large files have been deposited  :https://datadryad.org/stash/share/06d75FZ6GiPmme3HnKnkyTFbgKJ2mV0UVRaN-gVKoVE.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Gruber FS</collab><collab>Johnston ZY</collab><collab>Andrews P</collab><collab>Barratt CL</collab></person-group><year iso-8601-date="2019">2019</year><source>Data from: A phenotypic screening platform utilising human spermatozoa identifies compounds with contraceptive activity</source><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5061/dryad.jdfn2z36z">http://dx.doi.org/10.5061/dryad.jdfn2z36z</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.jdfn2z36z</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-51739-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>